FDA Inspection 1238909 — Merakris Therapeutics, LLC
The FDA completed an inspection of Merakris Therapeutics, LLC on May 15, 2024 in Research Triangle Park, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 15, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Research Triangle Park, NC (United States)